<DOC>
	<DOCNO>NCT02388529</DOCNO>
	<brief_summary>This study single-center , randomize , double-blind , placebo-controlled study patient stable heart failure evaluate safety , tolerability , pharmacokinetics , efficacy multiple ascending dos Bendavia™ ( MTP-131 ) intravenous infusion .</brief_summary>
	<brief_title>A Multiple Ascending Dose Study Evaluate Safety , Tolerability , Pharmacokinetics Efficacy Bendavia™ ( MTP-131 ) Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>LVEF ≤45 % 2D echocardiogram . Diagnosis New York Heart Association Class II III HF minimum 6 month prior Screening Visit . HF consider stable , judgment Principal Investigator hospitalization relate HF occur within 1 month prior Screening Visit . Treatment appropriate pharmacologic therapy HF include , limited , angiotensin convert enzyme inhibitor ( ACEI ) and/or angiotensin receptor blocker ( ARB ) , evidencebased beta blocker treatment HF Females childbearing potential must negative serum pregnancy test Screening Visit . Written inform consent obtain strictly adhere write guideline local Ethical Committee ( EC ) . Unstable angina pectoris within 1 month initiation screening procedure . Unstable angina define occurrence chest pain frequently usual , pain rest upon minimal exertion , protract episode pain without discernible trigger , and/or chest pain persist despite use vasodilatory therapy ( e.g. , nitroglycerin ) . Coronary peripheral artery revascularization procedure within 2 month prior Screening Visit . An acute myocardial infarction within 3 month prior Screening Visit . Supine rest heart rate ≥ 100 beat per minute 5 minute rest . Uncontrolled hypertension define systolic blood pressure ( BP ) &gt; 180 mm Hg diastolic BP &gt; 110 mm Hg least 2 consecutive reading . Requirement valve cardiac surgery ( e.g. , pericardectomy ) . Cardiac surgery valvuloplasty within 2 month prior Screening Visit . General surgery within 1 month prior Screening Visit . Restrictive cardiomyopathy , obstructive cardiomyopathy , pericardial disease , amyloidosis , infiltrative cardiomyopathy , uncorrected thyroid disease , dyskinetic leave ventricular aneurysm . Cerebrovascular accident transient ischemic attack within 3 month prior Screening Visit . Liver enzyme ( alanine aminotransferase [ ALT ] and/or aspartate aminotransferase [ AST ] ) elevation &gt; 3x upper limit normal ( ULN ) . Estimated glomerular filtration rate ( eGFR ) &lt; 30 mL/min , use Modification Diet Renal Disease ( MDRD ) Study equation . Known active drug alcohol abuse . Active infection require systemic treatment surgical intervention . Significant acute chronic medical psychiatric illness , judgment Investigator , could compromise subject safety , limit subject 's ability complete study , and/or compromise objective study . Female patient pregnant breastfeeding . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Bendavia™</keyword>
	<keyword>MTP-131</keyword>
</DOC>